Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
| Actual shortage: | 8 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 26 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56912 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-02-15 | 2019-03-01 | 76027 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-08-27 | 2019-10-10 | 92505 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-09-20 | 2019-10-10 | 94473 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-11-05 | 2019-11-12 | 97992 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-01-17 | 2020-02-11 | 103477 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-10 | 2020-03-21 | 108434 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-09-02 | 165961 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-08-30 | 165965 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-10-26 | 171211 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-12-01 | 171215 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-03-15 | 2023-03-31 | 187084 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-04-12 | 2023-04-29 | 189362 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197756 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-10-11 | 2023-10-24 | 206816 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Actual shortage | 2024-06-06 | 2024-06-08 | 229848 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7240 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7264 |
| ACID CONCENTRATE 2163 | 90G 10.8G 2.14G 6.24G 10.06G 275G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7249 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |